Literature DB >> 18264653

The pathogenesis of pterygium: current concepts and their therapeutic implications.

Jeanie Chui1, Nick Di Girolamo, Denis Wakefield, Minas T Coroneo.   

Abstract

Pterygium is a disease of the ocular surface that is associated with chronic UV exposure and is characterized by proliferation, inflammatory infiltrates, fibrosis, angiogenesis and extracellular matrix breakdown. Although pterygium is not fully understood, significant progress has been made toward understanding the mechanisms involved in its pathogenesis. In this review, we provide an update on the signaling pathways activated by UV light that result in induction of mediators responsible for the growth of pterygium. We also review the recent genetic studies on hereditary factors and provide a brief overview of the role of epithelial mesenchymal transition, bone marrow progenitor cells, and neuronal signals that may also contribute to the pathogenesis of pterygium. Therapeutic options for pterygium are discussed based on the mechanisms that perpetuate its growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264653     DOI: 10.1016/s1542-0124(12)70103-9

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  79 in total

1.  [Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Authors:  L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  [Pterygium surgery. Complication following adjuvant radiotherapy].

Authors:  C Lange; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

3.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Survivin and p53 expression in primary and recurrent pterygium in Chinese patients.

Authors:  Li-Wei Zhang; Bai-Hua Chen; Xing-Hua Xi; Qian-Qian Han; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

5.  Effect of porcine chondrocyte-derived extracellular matrix on the pterygium in mouse model.

Authors:  Hye Sook Lee; Ji Hyun Lee; Jae Wook Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-23       Impact factor: 3.117

Review 6.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

7.  Identification of pterygium-related mRNA expression profiling by microarray analysis.

Authors:  J Liu; X Ding; L Yuan; X Zhang
Journal:  Eye (Lond)       Date:  2017-06-30       Impact factor: 3.775

8.  The Key Role of VEGF in the Cross Talk between Pterygium and Dry Eye and Its Clinical Significance.

Authors:  Chang Liu; Yiyue Song; Xiaoran Wang; Zhaoguang Lai; Chaoyang Li; Pengxia Wan; Nuo Xu; Danping Huang; Yizhi Liu; Zhichong Wang
Journal:  Ophthalmic Res       Date:  2020-01-10       Impact factor: 2.892

9.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

10.  Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration.

Authors:  C J Jaworski; M Aryankalayil-John; M M Campos; R N Fariss; J Rowsey; N Agarwalla; T W Reid; N Dushku; C A Cox; D Carper; G Wistow
Journal:  Mol Vis       Date:  2009-11-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.